DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

OCCLLTD vs SUDARSHAN: Stock Comparison

OCCL vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

OCCL shows a lower P/E, a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

OCCLLTD leads 5; SUDARSHAN leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

OCCLLTDSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹760 Cr
₹0 Cr
P/E RatioOCCLLTD has the lower reading
0x ✓
28.27x
P/B RatioOCCLLTD has the lower reading
0x ✓
4.11x
EPSOCCLLTD has the higher reading
₹5.58 ✓
₹0.32
Book ValueContext only
₹86.34
₹6.14
Dividend YieldOCCLLTD has the higher reading
2.5% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
OCCLLTD has a lower P/E
0x vs 28.27x
P/B Ratio
OCCLLTD has a lower P/B
0x vs 4.11x
EPS
OCCLLTD has higher earnings per share
₹5.58 vs ₹0.32
Dividend Yield
OCCLLTD has a higher dividend yield
2.5% vs 0%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 17.01%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs -30.78%
Net Margin
OCCLLTD has a higher net margin
9.43% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricOCCLLTDSUDARSHAN
SectorChemicals—
IndustryCommodity Chemicals—

Price

MetricOCCLLTDSUDARSHAN
Live Price₹153.25₹32.71
Day Change-3.95%0.03%
Volume1.52 L92,985
52-Week High₹251₹39.3
52-Week Low₹75.71₹31.01
Distance from 52W High-38.94%-16.77%

Valuation

MetricOCCLLTDSUDARSHAN
Market Cap₹760 Cr₹0 Cr
P/E Ratio0x28.27x
P/B Ratio0x4.11x
EPS₹5.58₹0.32
Book Value₹86.34₹6.14
Dividend Yield2.5%0%

Growth

MetricOCCLLTDSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth17.01%24.4%
Qtr Profit Growth-30.78%38.7%

Profitability & Leverage

MetricOCCLLTDSUDARSHAN
ROE11.06%—
ROCE11.83%—
Net Margin9.43%0%
Operating Margin11.96%—
Debt to Equity0.2x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricOCCLLTDSUDARSHAN
Promoter Holding51.76%57.81%▼ 1.12 pp
FII Holding0.18%▼ 0.09 pp21.95%▲ 2.57 pp
DII Holding4.75%0%
Public Holding43.3%▲ 0.09 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: OCCL and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.